It has been found that dermatan polysulfates (DPS) I, II and III isolated from hagfish notochord, hagfish skin and shark skin, respectively, and chemically sulfated dermatan sulfate exhibit considerable anticoagulant activity in the "activated partial thromboplastin time (APTT)" system. On comparing the activities with the various compositions, including disaccharide units produced by the digestion with chondroitinase-ABC, it was shown that the activity of these dermatan polysulfates depends not only on the total sulfate content but also on the content of sulfated Liduronic acid residues. The activity seemed to decrease for molecular weight of below 10,000. The effect of these dermatan polysulfates on the inactivation of the clotting enzymes, factor Xa and thrombin, by antithrombin III (AT-III) was also studied using chromogenic substrates for the assay of the enzyme activities. The dermatan polysulfates showed an inhibitory effect on thrombin-AT-III, as estimated by the APTT assay, in contrast with the effect on factor Xa-AT-III which was found to be very small. anticoagulant activity; dermatan polysulfates; APTT of sulfated glycosaminoglycans.
Heparin is known as a biologically active glycosaminoglycan having anticoagulant activity, lipemia clearing activity, etc. A number of studies have attempted to define the chemical and physical properties of heparin that are responsible for its anticoagulant action. Although the precise relationship between the structure of heparin and its biological activity has not yet been demonstrated, it is thought that the activity may be related to the total sulfate content (Wolfrom 
DIPS-I, dermatan polysulfate I from hagfish notochord; DPS-II, dermatan polysulfate II from hagfish skin; DPS-III, dermatan polysulfate III from shark skin; ChS-A, chondroitin sulfate A; ChS-E, chondroitin sulfate E; ChS-K, chrondroitin sulfate K; APTT, activated partial thromboplastin time; AT-III, antithrombin ITI; Xa, factor Xa. Hurst et al. 1979) , the content and distribution of Nsulfated glucosamine (Yosizawa et al. 1967; Cifonelli 1974; Nagasawa et al. 1977) , the proportion of L-iduronic acid or sulfated L-iduronic acid (Cifonelli 1974 Barrowcliffe et al. 1979 ) and so on.
Previously we isolated three kinds of dermatan polysulfate, DPS-I (Anno et al. 1971), DPS-II (Seno et al. 1972 ) and DPS-III (Seno and Meyer 1963) from hagfish notochord, hagfish skin and shark skin, respectively, and the differences in the degree of sulfation and the position of sulfate groups were found.
The present paper reports the anticoagulant activities of these dermatan polysulfates and chemically sulfated dermatan sulfate (SDS) in the APTT system, and the influence of these glycosaminoglycans on the inactivation of Xa and thrombin by AT-III, and discusses the relationship between the structure and the activities. ) were isolated as previously described. Dermatan sulfate prepared from chicken comb was obtained from Seikagaku Kogyo Co., Ltd. and was purified by ethanol fractionation. These preparations showed no heparin contamination in terms of their amino sugar composition and electrophoretic nature. Heparin (165 units/mg) was purchased from Wako Pure Chemical Industries, Ltd. Blood coagulant factor Xa and thrombin, chromogenic substrates 5-2222 for Xa and 5-2238 or S-2160 for thrombin, and AT-III were purchased from Kabi Diagnostic Inc. Cephalin reagent (ACTIN) was purchased from Date Diagnostic Inc. Chondroitinase-ABC (EC 4.2.2.4) was purchased from Seikagaku Kogyo Co., Ltd.
MATERIALS AND METHODS

Materials
Analytical methods. Uronic acid, hexosamine, sulfate and reducing values were determined as previously described ).
Sulfation of dermatan sulfate and ChS-A. Sulfation of dermatan sulfate and ChS-A was carried out essentially by the method of Nagasawa et al. (1971) except that the reaction was performed at -30°C for 1 hr and then at 0°C for 2 hr before neutralization. The sulfated dermatan sulfate and ChS-A thus obtained were tentatively named "SDS" and "SChS-A", respectively.
Assay for anticoagulant activity APTT assay. Citrated plasma (100 µl) containing glycosaminoglycan was mixed with 100 ,ul of cephalin reagent and pre-warmed for 6 min at 37°C. After addition of 100 fcl of 20 mM CaC12 into the mixture, clotting time was recorded manually or with a coagulation profiler.
The effect o f glycosaminoglycans on the inactivation o f X a and thrombin by AT-Ill. The influence of glycosaminoglycans on the inactivation of Xa and thrombin by AT-III was measured in two stage assays without polybrene, according to the method described by Teien et al. (1976) with the exception of a time modification. The reaction times of glycosaminoglycan mixed with AT-III and the factor were 2 min for Xa and 4 min for thrombin.
Chondroitinase-ABC digestion. The disaccharide composition of the dermatan polysulfates was determined by the analysis of unsaturated disaccharides produced by Chondroitinase-ABC digestion (Saito et al. 1968 ). The undegraded material from SDS was separated as follows : SDS (19.7 mg) dissolved in 0.05 M Tris-HC1 buffer (pH 8.0) was digested with chondroitinase-ABC (12 units/0.8 ml) at 37°C overnight. The supernatant, obtained after heating for 1 min at 100°C was passed through Dowex 50 (H+ form) and then applied on a column of Sephadex G-50 (1.4x 139 cm) in 10% ethanol. The fraction eluted in the void volume was collected and termed "SDS-R".
RESULTS AND DISCUSSION
The auticoagulant effects of the various glycosaminoglycans, estimated by APTT assay, are summarized in Table 1 , with the molar ratio of sulfate to hexosamine. The effects are expressed as heparin activity, in which "ts" and "tb" are the clotting time in the presence and absence of glycosaminoglycan, respectively. A heparin activity curve is shown in Fig. la . Highly sulfated glycosaminoglycans of both the dermatan sulfate type and the chondroitin sulfate type showed significant activity. The activities of SDS, DPS-II and SDS-R correspond to about 20%, 15% and 15% of heparin activity, respectively, while those of DPS-I and DPS-III were lower than 5% of heparin activity.
In Figs. lb and lc, the activity curves of DPS-I and DPS-II are shown. Similar shapes to that for heparin were found, indicating that these dermatan polysulfates have a heparin-like effect on the clotting of citrated plasma. The activity of DPS-II estimated by APTT assay, was found to be 3 times higher than that of DPS-I, regardless of an almost equal content of sulfate.
In order to define the relationship between the activity and the structure for the various dermatan polysulfates, the disaccharide units produced by digestion with chondroitinase-ABC were compared ( Table 2 ). The main disaccharide from BPS-I was dDi-diSE composed of unsaturated uronic acid and 4,6-disulfated Nacetylgalactosamine. On the other hand, DPS-II, DPS-III and SDS gave dDidiSB with or without dDi-diSD and/or 4Di-triS, which contain unsaturated uronic acid sulfate originating from the sulfated L-iduronic acid residues, in addition to dDi-4S, dDi-6S and dDi-diSE. Undigested materials, SDS-R, obtained after the digestion of SDS, appeared to be composed almost entirely of trisulfated disaccharide residues having sulfated L-iduronic acid, on the basis of the molar ratio TABLE 1. Anticoagulant activity of glycosaminoglycans measured by APTT of sulfate to hexosamine -as calculated from the disaccharide units produced from SDS and the ratio of original SDS. From these results, the yields of disaccharides containing sulfated L-iduronic acid residues from DPS-II, DPS-III and SDS were estimated to be 56%, 24% and 62%, respectively. Consequently, it was considered that the activity of dermatan polysulfates depends not only on the total sulfate content but also on the content of sulfated L-iduronic acid residues.
The activity of SDS-R, however, was not higher than that of SDS but close to that of DPS-TI, although the content of total sulfate and sulfated L-iduronic acid residues appeared to be higher.
Since the average molecular weight of SDS-R was estimated by its reducing value as to be 1/3 of that of SDS, the molecular size may also contribute to the activity as another factor. Among chondroitin polysulfates, ChS-E, ChS-K and SChS-A the more highly sulfated chondroitin polysulfates showed the higher activities. Chitin sulfate did not prolong the clotting time, in spite of a higher sulfate content (S04/disaccharide=2.2). The free carboxyl groups of uronic acid residues may also be an important contributing factor affecting the activity.
The influence of the dermatan Polysulfates on the inactivation of the clotting enzymes, Xa and thrombin, by AT-III was studied using chromogenic substrates for the assay of enzyme activity. In Table 3 , the dermatan polysulfates can be seen to have scarcely affected the inactivation of Xa by AT-III. Recently it was suggested that the inactivation of Xa by AT-III was related to the presence of Ca2+ and phospholipid (Walker and Esmon 1979) , so that it would be of interest to study the effect of these dermatan polysulfates on Xa-AT-III system in the presence of these substances.
The dermatan polysulfates described above accelerated the inactivation of thrombin by AT-III (Fig. 2) and the concentrations required to inactivation effect were the same for all dermatan polysulfates.
The mechanisms of heparin action on the inactivation of the clotting enzymes by AT-III have been mainly studied on the thrombin-AT-III system. AT-III is thought to block a serine residue at the active center of thrombin which then results in the occurrence of anticoagulation. Binding of heparin to AT-III, before •-., DPS-I; DPS-II; x -x, SDS; o-o, heparin; .-A, dermatan sulfate.
the reaction of thrombin with AT-III, results in the acceleration of the rate of inactivation of thrombin by AT-III. The binding of heparin to AT-III has been thought to be between the sulfate groups of heparin and the lysine residues of AT-III (Rosenberg et al. 1973 ). In the present experiment, with a relatively lower level of sulfate in the dermatan polysulfate, there was no effect on the reaction, in contrast to the more highly sulfated dermatan polysulfates which had a considerable effect, indicating that this reaction requires a critical range in the sulfate content. Rosenberg and Lam (1979) reported that a tetrasaccharide, IdUAa1-*4G1cNAc (6S) a1-4G1cUA/1--*4G1cNS (6S) represents the critical sequence responsible for anticoagulant activity.
On the other hand, Thunberg et al. (1980) proposed that an octasaccharide, IdUAa1-~4G1cNAca1-+ 4G1cUA/31-* 4G1cNS(6X)al-> 4IdUA(2S)al-~ G1cNS(6X)al-~ 4IdUA(2S)al-~4G1cNS(6X)(X=H or 503-), is the smallest oligosaccharide for binding to AT-III.
Furthermore, they reported that a 3-0-sulfated glucosamine residue is a unique component of the AT-III binding sequence in high-affinity heparin (Lindhal et al. 1980) ; and that N-sulfates at the specific positions of that octasaccharide are also required for high affinity binding of heparin to AT-III (Riesenfeld et al. 1981) .
In view of the fact that the concentration of heparin in physiologically normal blood appears to be rather too low to fulfill entirely the anticoagulant function, dermatan sulfate which lines the blood vessel wall may well function as an anticoagulant in the blood. Further studies on the dermatan polysulfates having the high activity demonstrated here may therefore be of value in the understanding of anticoagulant phenomena.
